Find out how experts at the Ellison Institute are harnessing new cell monitoring technology to build cancer cell biobanks and enhance cell line quality control and authentication
Antibodies available are specific for S1, S2 and receptor-binding domain regions of SARS-CoV-2 Spike protein
Combination test for COVID-19, flu and other common respiratory illnesses helps health care professionals prepare for flu season
The Phase II clinical trial, which will use cutting-edge CRISPR genetic engineering, has already begun enrolling patients
The addition of COVID-19 antibody tests to the portfolio aims to further support the pandemic response on multiple fronts
Access SARS-CoV-2 IgG assay shows excellent agreement with the Genscript Surrogate Virus Neutralization Test
Fluidigm COVID-19 campus safeguard program improves availability of non-invasive, saliva-based SARS-CoV-2 tests for higher education institutions
Researchers have made a significant COVID-19 drug target discovery using Thermo Fisher Scientific CryoEM technology
CE mark for MitraClip G4 offers physicians an innovative next-generation system with more options for mitral valve repair using proven clip-based technology
Promega and Incyte intend to work together in the future to develop the Promega OncoMate MSI Assay as a companion diagnostic
The Direct assay is validated on a wide range of specimen types, and can be run in parallel with the Simplexa Flu A/B & RSV Direct Gen II assay
cPass is first commercially available product to rapidly detect neutralizing antibodies capable of eliminating virus
Join Waters on Wednesday, October 7, for a panel discussion and insights from the USP and MHRA
The new line aims to provide unmatched sensitivity, resolution, speed, and flexibility of colors
AstraZeneca anticipates entering clinical development in 2021
The technology is said to be superior at identifying cell types in human blood, providing faster and more reliable assessments for clinical decision making
The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus
The partnership aims to co-market exosome technology as well as the joint development of new exosome based products
The collaboration aims to define threshold for neutralizing antibody sufficient to confer immunity
New indication allows this first FDA-approved biomarker-based test to be used as triage for positive cobas HPV tests run on cobas 6800/8800 Systems in primary screening or co-testing programs
New research published in Nature Immunology show strong T cell responses in patients recovered from COVID-19
New test expands Roche molecular test menu for transplant patients, enabling simultaneous testing of BK virus with Cytomegalovirus and Epstein-Barr virus
Sanofi and GSK are scaling up the manufacturing of the antigen and adjuvant with the target of producing up to one billion doses in 2021
Data shows 100% concordance with results from Dartmouth-Hitchcock’s lab-based polymerase chain reaction (PCR) test method
